Manuel Alba Sells 183,000 Shares of Astera Labs (NASDAQ:ALAB) Stock

Astera Labs, Inc. (NASDAQ:ALAB) Director Manuel Alba sold 183,000 shares of the stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total value of $51,263,790.00. Following the transaction, the director owned 253,863 shares in the company, valued at approximately $71,114,642.19. This trade represents a 41.89% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Manuel Alba also recently made the following trade(s):

• On Wednesday, July 1st, Manuel Alba sold 136,974 shares of Astera Labs stock. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74.
• On Wednesday, July 1st, Manuel Alba sold 37,535 shares of Astera Labs stock. The stock was sold at an average price of $447.39, for a total value of $16,792,783.65.
• On Wednesday, July 1st, Manuel Alba sold 8,491 shares of Astera Labs stock. The shares were sold at an average price of $458.38, for a total transaction of $3,892,104.58.

Astera Labs Stock Performance

Shares of ALAB stock opened at $310.40 on Friday. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48. The stock has a market cap of $53.85 billion, a price-to-earnings ratio of 153.66 and a beta of 3.77. The firm has a fifty day moving average of $330.74 and a 200-day moving average of $254.36.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. During the same period in the prior year, the firm posted $0.44 EPS. Astera Labs’s quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages recently weighed in on ALAB. Royal Bank Of Canada upped their target price on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Susquehanna boosted their price target on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research report on Friday, July 31st. Bank of America lifted their target price on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research note on Tuesday, June 23rd. UBS Group restated a “neutral” rating and issued a $425.00 price target on shares of Astera Labs in a research note on Wednesday, August 5th. Finally, Zacks Research raised Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $348.33.

Institutional Investors Weigh In On Astera Labs

Several institutional investors and hedge funds have recently made changes to their positions in ALAB. California State Teachers Retirement System lifted its stake in shares of Astera Labs by 49,273.2% in the 2nd quarter. California State Teachers Retirement System now owns 100,158,544 shares of the company’s stock valued at $48,378,580,000 after purchasing an additional 99,955,684 shares during the period. BlackRock Inc. bought a new position in Astera Labs during the second quarter worth $6,609,581,000. Bank of America Corp DE acquired a new stake in Astera Labs in the second quarter worth $1,061,791,000. Atreides Management LP grew its holdings in Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after purchasing an additional 1,754,593 shares during the period. Finally, Amundi boosted its position in shares of Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after purchasing an additional 1,319,643 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs News Roundup

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Demand for Astera Labs’ Scorpio, Aries and Taurus connectivity platforms is supporting expectations for strong third-quarter growth and strengthening the company’s position in AI data-center infrastructure. ALAB Stock Down 24% in a Month: Should Investors Buy the Dip or Wait?
• Positive Sentiment: The company’s latest quarterly results exceeded expectations, with earnings per share of $0.80 versus the $0.69 consensus estimate and revenue of $392.4 million versus $360.85 million. Revenue rose 104.5% year over year, while management issued third-quarter EPS guidance of $1.16 to $1.21.
• Positive Sentiment: Analyst sentiment remains generally constructive: Astera Labs has a “Moderate Buy” consensus rating and an average price target of $348.33, above recent trading levels. Northland upgraded the shares to outperform with a $350 target, while Morgan Stanley maintained an overweight rating with a $335 target.
• Neutral Sentiment: Despite the favorable growth outlook, ALAB has declined 13.9% since its latest earnings report and 24% over the past month, reflecting elevated valuation expectations and uncertainty about the pace of future growth. The stock’s high beta and elevated earnings multiple may contribute to volatility. Why Is Astera Labs Down Since Its Earnings Report?
• Negative Sentiment: Director Manuel Alba sold 183,000 shares for approximately $51.3 million, reducing his holdings by 41.9%. Director Stefan Dyckerhoff separately sold 12,499 shares worth about $3.4 million. The transactions were made under pre-arranged Rule 10b5-1 plans, which reduces their value as a discretionary bearish signal, but the sales may still weigh on investor sentiment and add near-term supply. SEC Insider Trading Filing

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.